Your browser doesn't support javascript.
loading
Augmenting NK cell-based immunotherapy by targeting mitochondrial apoptosis.
Pan, Rongqing; Ryan, Jeremy; Pan, Deng; Wucherpfennig, Kai W; Letai, Anthony.
Afiliação
  • Pan R; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA; Harvard Medical School, Boston, MA 02215, USA. Electronic address: rongqing_pan@dfci.harvard.edu.
  • Ryan J; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA; Harvard Medical School, Boston, MA 02215, USA.
  • Pan D; Harvard Medical School, Boston, MA 02215, USA; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA.
  • Wucherpfennig KW; Harvard Medical School, Boston, MA 02215, USA; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA.
  • Letai A; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA; Harvard Medical School, Boston, MA 02215, USA. Electronic address: anthony_letai@dfci.harvard.edu.
Cell ; 185(9): 1521-1538.e18, 2022 04 28.
Article em En | MEDLINE | ID: mdl-35447071

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células Matadoras Naturais / Imunoterapia / Neoplasias Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células Matadoras Naturais / Imunoterapia / Neoplasias Idioma: En Ano de publicação: 2022 Tipo de documento: Article